CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AstraZeneca Pharmaceuticals LP v. Teva Parenteral Medicines Inc.

1:10-cv-00018

Overview

Case Number 1:10-cv-00018
Filing Date 2010-01-07
Status Terminated
Termination Date 2011-06-15
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Defendant

Parties

Defendant

Teva Pharmaceutical Industries Ltd Operating Company

Represented By

1 Attorneys Listed

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Teva Pharmaceuticals USA Inc. Operating Company

Represented By

7 Attorneys Listed

Todd J. Ehlman

Email: tehlman@winston.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John R. McNair

Email: jmcnair@winston.com

Ivan M. Poullaos

Email: ivan.poullaos@winstontaylor.com

George C. Lombardi

Email: glombard@winston.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Teva Parenteral Medicines Inc. Operating Company

Represented By

7 Attorneys Listed

Todd J. Ehlman

Email: tehlman@winston.com

Megan C. Haney

Phillips, Goldman, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, Goldman, McLaughlin & Hall, P.A., 1200 North Broom Street

John R. McNair

Email: jmcnair@winston.com

Ivan M. Poullaos

Email: ivan.poullaos@winstontaylor.com

George C. Lombardi

Email: glombard@winston.com

Brian E. Farnan

Farnan LLP

Tel: +1 (302) 777-0300
Fax: +1 (302) 777-0301

919 North Market Street, 12th Floor

John C. Phillips , Jr.

Phillips, McLaughlin & Hall, P.A.

Tel: +1 (302) 655-4200

Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St

Plaintiff

AstraZeneca AB NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Kristen Healey Cramer

Benesch, Friedlander, Coplan, and Aronoff LLP

Tel: +1 (302) 442-7010

1313 North Market Street, Suite 1201

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

AstraZeneca UK Limited NPE (University / Research)

Represented By

2 Attorneys Listed

Kristen Healey Cramer

Benesch, Friedlander, Coplan, and Aronoff LLP

Tel: +1 (302) 442-7010

1313 North Market Street, Suite 1201

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

AstraZeneca Pharmaceuticals, LP NPE (Individual / Inventor)

Represented By

2 Attorneys Listed

Kristen Healey Cramer

Benesch, Friedlander, Coplan, and Aronoff LLP

Tel: +1 (302) 442-7010

1313 North Market Street, Suite 1201

Mary W. Bourke

Womble Bond Dickinson (US) LLP

Tel: +1 (302) 252-4320

1313 North Market Street, Suite 1200

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 3 proceedings
🏛️
USPTO PTAB Trials 7 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): GB 🇺🇸 US
Parallel Proceedings Across Jurisdictions (10 found):
PTAB: 7 U.S. Courts: 3
USPTO PTAB Trial 2017-08-04
IPR2017-01912

FRESENIUS KABI USA, LLC v. AstraZeneca AB

U.S. Continuation Sibling (8466139)
Status: Institution Denied
USPTO PTAB Trial 2017-08-04
IPR2017-01910

Fresenius Kabi USA,LLC v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Institution Denied
USPTO PTAB Trial 2017-02-17
IPR2017-00905

InnoPharma Licensing LLC et al. v. AstraZeneca AB

U.S. Continuation Sibling (8466139)
Status: Institution Denied
USPTO PTAB Trial 2017-02-17
IPR2017-00904

InnoPharma Licensing LLC et al. v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Institution Denied
USPTO PTAB Trial 2016-06-29
IPR2016-01326

Mylan Pharmaceuticals Inc. v. AstraZeneca AB

U.S. Continuation Sibling (8466139)
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01324

Mylan Pharmaceuticals Inc. v. AstraZeneca AB

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2016-06-29
IPR2016-01316

Mylan Pharmaceuticals Inc. v. AstraZeneca AB

U.S. Continuation Sibling (6774122)
Status: Terminated-Settled
U.S. District Court 2017-12-14
1:17-cv-01795

AstraZeneca Pharmaceuticals LP v. Fresenius Kabi USA, LLC

Asserted Patent
Status: DED
U.S. District Court 2016-08-05
1:16-cv-00669

AstraZeneca Pharmaceuticals LP v. Mylan Institutional LLC

Asserted Patent
Status: DED
U.S. District Court 2014-06-03
1:14-cv-03547

ASTRAZENECA PHARMACEUTICALS LP v. SAGENT PHARMACEUTICALS, INC.

Asserted Patent
Status: NJD
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

2 Patents

There are 2 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6774122
Formulation
Filed: 2001-01-09
Issued: 2004-08-10
Expired (Term Ended)
Expires: 2021-01-09
US7456160
Formulation
Filed: 2004-06-22
Issued: 2008-11-25
Expired (Term Ended)
Expires: 2023-06-01

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Statutorily Barred

Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

1

Dispositive

0

Granted

0

Denied

0

Pending / Review

1

Motions by Category

Procedural / Extension Motion 1

Key Dispositive Motions & Rulings

Procedural / Extension Motion Pending / Under Review
STIPULATION to Extend Time to Answer, Move or Otherwise Respond to Plaintiffs' Complaint re 1 Complaint, by Teva Parenteral Medicines Inc., Teva Pharmaceuticals...
Entry #9 • 2010-02-24 Document →

Docket Entries

(43 total)
Pleading / Complaint

COMPLAINT filed against Teva Parenteral Medicines Inc., Teva Pharmaceutical Industries Ltd, Teva Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 350, receipt number 0311-676867.) - filed by AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited, AstraZeneca AB. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Civil Cover Sheet)(mxw, ) (Entered: 01/08/2010)

Entry #1 • 2010-01-07
1

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction (mxw, ) (Entered: 01/08/2010)

Entry #2 • 2010-01-07
1

Summons Issued as to Teva Parenteral Medicines Inc. on 1/7/2010; Teva Pharmaceutical Industries Ltd on 1/7/2010; Teva Pharmaceuticals USA Inc. on 1/7/2010. (mxw, )

Entry #3 • 2010-01-07
1
No Actions

Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,774,122 B2; 7,456,160 B2; (mxw, ) (Entered: 01/08/2010)

Entry #3 • 2010-01-08
1

Disclosure Statement pursuant to Rule 7.1 filed by AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited identifying Corporate Parent AstraZeneca PLC for AstraZeneca AB, AstraZeneca Pharmaceuticals LP, AstraZeneca UK Limited.. (Bourke, Mary) (Entered: 01/12/2010)

Entry #4 • 2010-01-12
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc